Large-scale testing (Phase 3)Active Not RecruitingNCT04337450
What this trial is testing
DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years Old
Who this might be right for
HIV Infections
PENTA Foundation 386